EUVIMEDDescubrir EUVIMED
Klinische Studie

Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor

H Tohgi, T Abe, S Takahashi, M Saheki, M Kimura

Journal of Neural Transmission - Parkinson's Disease and Dementia Section · 1995-06 · 9 (2-3) · 121-131

DOI: 10.1007/bf02259654 ↗

At a glance

Klinische Studie in Journal of Neural Transmission - Parkinson's Disease and Dementia Section, published online on 1995-06-01. Written by H Tohgi and 4 co-authors. Institution: Department of Neurology, Iwate Medical University, Morioka, Japan. Cited 20 times so far (Crossref); 34 references.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

We studied changes in the concentrations of serotonin (5-HT), kynurenine, and other indoleamines in the cerebrospinal fluid of patients with Alzheimer type dementia (ATD) and those with Binswanger type vascular dementia (VDBT), and changes in these indoleamine concentrations 2 weeks after administration of citalopram, a 5-HT uptake inhibitor. The concentrations of total 5-HT (p < 0.005) and kynurenine (p < 0.005) were significantly decreased in ATD patients in comparison to those of the controls. After citalopram administration, there was a remarkable increase in 5-HT concentration (249%, p < 0.0001) and a significant decrease in 5-HIAA concentration (22%, p < 0.02). In the VDBT patients, only 5-HT showed a significant decrease (p < 0.005) in comparison to the control values. It also increased significantly (214%) after citalopram administration. The 5-HT/tryptophan and kynurenine/tryptophan ratios were not correlated for the controls, but did significantly for the ATD and VDBT patients; after citalopram treatment, the increase in 5-HT/tryptophan was correlated significantly with that of kynurenine/tryptophan for ATD, but not for VDBT. These results suggest that both the serotonin and kynurenine pathways are impaired in ATD; whereas, the serotonin pathway alone is in VDBT, and that these impairments are ameliorated by the administration of citalopram.

Subjects

MeSH terms (MEDLINE)

AgedAlzheimer DiseaseCitalopramDementia, VascularHumansIndolesKynurenineSerotoninSelective Serotonin Reuptake Inhibitors

Substances

CitalopramIndolesKynurenineSerotoninSelective Serotonin Reuptake Inhibitors

Authors and institutions

  • Department of Neurology, Iwate Medical University, Morioka, Japan.

Cite

APA

Tohgi, H., Abe, T., Takahashi, S., Saheki, M., & Kimura, M. (1995). Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. Journal of Neural Transmission - Parkinson's Disease and Dementia Section, 9(2-3), 121-131. https://doi.org/10.1007/bf02259654

Vancouver

Tohgi H, Abe T, Takahashi S, Saheki M, Kimura M. Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. Journal of Neural Transmission - Parkinson's Disease and Dementia Section. 1995;9(2-3):121-131. doi:10.1007/bf02259654

BibTeX
@article{Tohgi1995,
  author = {Tohgi, H and Abe, T and Takahashi, S and Saheki, M and Kimura, M},
  title = {Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dementias before and after administration of citalopram, a synthetic serotonin uptake inhibitor},
  journal = {Journal of Neural Transmission - Parkinson's Disease and Dementia Section},
  year = {1995},
  volume = {9},
  number = {2-3},
  pages = {121--131},
  doi = {10.1007/bf02259654}
}
Start for free →